Product Overview
[Drug Name]
Trade Name: Jianlisi
English Name: Lansoprazole Tablets
Chinese Pinyin: Lansuolazuopian
[Ingredients]
Lansoprazole
[Properties]
White enteric-coated tablets, appearing white or off-white after removal of the enteric coating.
[Indications]
Gastric ulcer, duodenal ulcer, reflux esophagitis, Zollinger-Ellison syndrome (gastrinoma).
[Dosage and Administration]
For the treatment of gastric ulcer and duodenal ulcer, take 15-30 mg orally once daily in the morning, or as directed by a physician.
[Adverse Reactions]
Side effects are mild, primarily manifesting as dry mouth, dizziness, and nausea.
[Contraindications]
Prevent use in pregnant and lactating women.
[Precautions]
No experience with pediatric use.
[Use in Special Populations]
Precautions for use in children:
Safety for pediatric use has not been established (very limited clinical experience in pediatric patients).
Precautions for Pregnancy and Lactation:
Pregnant and lactating women should not use this medication.
Precautions for the Elderly:
Elderly patients may experience decreased gastric acid secretion and other physiological functions, so please observe carefully during medication use.
[Drug Interactions]
Not yet known.
[Pharmacological Action]
This is a new drug that inhibits gastric acid secretion. It acts on the H+-K+-ATPase enzyme in gastric parietal cells, preventing H+ from being transported into the stomach, significantly reducing the amount of gastric acid in gastric juice. It is clinically used to treat duodenal ulcers, gastric ulcers, reflux esophagitis, and Zollinger-Ellison syndrome (gastrinoma). It has significant efficacy and is effective against Helicobacter pylori.
[Storage]
Store in a cool, dark, dry place, sealed and protected from light.
[Strength]
15 mg
[Packaging]
14 tablets/box
[Expiry Date]
24 months
[Approval Number]
National Medical Products Approval No. H20065318
[Manufacturer]
Lepu Pharmaceutical Co., Ltd.
